Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Chubb
Harvard Business School
Chinese Patent Office
Accenture
Baxter
Merck
Cipla

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021196

« Back to Dashboard

NDA 021196 describes XYREM, which is a drug marketed by Jazz Pharms and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug and one Paragraph IV challenge. Additional details are available on the XYREM profile page.

The generic ingredient in XYREM is sodium oxybate. There are one thousand four hundred and twenty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sodium oxybate profile page.
Summary for 021196
Tradename:XYREM
Applicant:Jazz Pharms
Ingredient:sodium oxybate
Patents:18
Therapeutic Class:Central Nervous System Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021196
Suppliers and Packaging for NDA: 021196
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
XYREM sodium oxybate SOLUTION;ORAL 021196 NDA Jazz Pharmaceuticals, Inc. 68727-100 N 68727-100-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength500MG/ML
Approval Date:Jul 17, 2002TE:AARLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jul 4, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Jul 4, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Jun 16, 2024Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF TREATING A PATIENT WITH A PRESCRIPTION DRUG USING A COMPUTER DATABASE IN A COMPUTER SYSTEM FOR DISTRIBUTION

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Fish and Richardson
UBS
Daiichi Sankyo
Queensland Health
Cerilliant
Chinese Patent Office
Teva
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.